A phase II study of Xcellerated T cells™ in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (NHL)John G. Gribben, Mark W. Frohlich, Joe Stephenson et al.|Transplantation and Cellular Therapy|2005Cited by 1